Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
2 Beaten-Down Dividend Stocks to Buy and Hold
Tickers BMY CVS
Tags Market News CVS BMY
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ALT AMGN BMY BSX
Tags Market News Options BMY
From Benzinga
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
Tickers BMY NEWS SYRS
Tags why it's moving News Trading Ideas
From Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Tickers ABBV BMY NBIX NEWS
Tags Equities Market News NBIX
From Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Tickers ARGX BMY IFF IHRT
Tags IFF ARGX Benzinga
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Tickers ABBV BMY LLY NEWS
Tags General Upgrades Analyst Ratings
From Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
Tickers ABBV BMY NEWS
Tags Market News Movers BMY
From Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
Tickers ABBV BMY NEWS
Tags Briefs BMY Movers
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Tickers BMY EVO NEWS NVO
Tags Biotech Stories That Matter Benzinga
From Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags Large Cap Trading Ideas News
From Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Tickers AFRM BMY BTBT BTDR
Tags LMND RDNT big gainers
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Tickers ABBV ALNY BMY GILD
Tags General ALNY Benzinga
From Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Tickers BMY NEWS NVO TEVA
Tags News Large Cap TEVA
From Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Tickers BMY MRK NEWS SMMT
Tags why it's moving General Analyst Ratings
From Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Tickers BMY
Tags BZI/SHORTHIST Market News Trading Ideas
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
Tickers BMY NEWS
Tags Top Stories Benzinga General
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags META SO QQQ
From Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
Tickers BMY
Tags BMY Recent Press Releases Market News
From Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
Tickers BMY NEWS
Tags Market News Movers BMY
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Equities NVS Briefs
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags NVS BMY Briefs
From Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
Tickers BMY
Tags BZI/UOA Benzinga Market News
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Tickers BMY IBRX MRK NEWS
Tags Trading Ideas News Analyst Color
From Benzinga
Why Is Evotec Stock Gaining Today?
Tickers BMY EVO NEWS
Tags why it's moving General Benzinga
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags General TAK Analyst Ratings
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags Market News JNJ Recent Press Releases
From Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Tickers BMY CATX NEWS
Tags BMY Briefs Market News
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Top Stories Benzinga General
From Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Tickers BMY
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags NVCR BMY HUM
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.